The G500 allele predicted a shorter progression time from primary to metastatic melanoma, a reduced tumor free survival period in individuals with bladder carcinoma, and was associated with loss of p16INK4a expression in sporadic colorectal cancer [15], [16], [17]. The gene discussed is CDKN2A; the disease is neoplasm.